SBW Life Sciences Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 1,196.86 million compared to KRW 0.00001 million a year ago. Net loss was KRW 777.12 million compared to KRW 9,228.91 million a year ago. Basic loss per share from continuing operations was KRW 4 compared to KRW 52 a year ago. Diluted loss per share from continuing operations was KRW 4 compared to KRW 52 a year ago. Basic loss per share was KRW 4 compared to KRW 52 a year ago.
For the six months, sales was KRW 1,415.94 million compared to KRW 0.00001 million a year ago. Net income was KRW 233.78 million compared to net loss of KRW 8,521.93 million a year ago. Basic earnings per share from continuing operations was KRW 1 compared to basic loss per share from continuing operations of KRW 49 a year ago. Diluted earnings per share from continuing operations was KRW 1 compared to diluted loss per share from continuing operations of KRW 49 a year ago. Basic earnings per share was KRW 1 compared to basic loss per share of KRW 49 a year ago.